BioCentury | Jul 2, 2007
Company News

GeneMax, University of British Columbia deal

...not disclosed. Also, GMXX changed its name to TapImmune Inc. and its ticker to TPIM. GeneMax Corp....
BioCentury | Feb 21, 2005
Company News

GeneMax board of directors update

GeneMax Corp. (GMXX), Vancouver, B.C. Business: Cancer, Infectious Appointed: Glynn Wilson, president and CEO of Auriga Pharmaceuticals WIR Staff cancer Infectious...
BioCentury | Feb 21, 2005
Company News

GeneMax management update

GeneMax Corp. (GMXX), Vancouver, B.C. Business: Cancer, Infectious Promoted: Konstantine Sarafis to president, CEO and a director from COO; he replaces Ronald Handford, who resigned WIR Staff cancer Infectious...
BioCentury | Sep 6, 2004
Company News

GeneMax management update

GeneMax Corp. (GMXX; FSE:GX1), Vancouver, B.C. Business: Autoimmune, Cancer, Infectious Hired: Konstantine Sarafis as COO, formerly an industry consultant WIR Staff autoimmune cancer Infectious...
BioCentury | Jul 26, 2004
Clinical News

GeneMax preclinical data

...retarded tumor growth. Data were presented at the International Congress of Immunology meeting in Montreal. GeneMax Corp....
BioCentury | Jun 21, 2004
Company News

GeneMax board of directors update

GeneMax Corp. (GMXX), Blaine, Wash. Business: Cancer, Infectious, Autoimmune Resigned: Grant Atkins WIR Staff...
BioCentury | Jun 21, 2004
Company News

GeneMax management update

GeneMax Corp. (GMXX), Blaine, Wash. Business: Cancer, Infectious, Autoimmune Hired: Edward Farrauto as CFO, treasurer and secretary WIR Staff autoimmune cancer Infectious...
BioCentury | Feb 23, 2004
Company News

GeneMax, University of British Columbia deal

...GMXX's GeneMax Pharmaceuticals Inc. subsidiary (Vancouver, B.C.) received an exclusive worldwide license from the university to...
...worldwide license from the university to an assay that screens compounds that regulate immune responses. GeneMax Corp....
BioCentury | Nov 24, 2003
Company News

GeneMax, National Institutes of Health deal

GeneMax Corp. (GMXX), Blaine, Wash. National Institutes of Health , Bethesda, Md. Business: Infectious GMXX obtained a non-exclusive worldwide license from the NIH's National Institute of Allergy and Infectious Diseases (NIAID) to Modified Vaccinia Ankara IP...
BioCentury | Aug 18, 2003
Company News

Crucell, GeneMax deal

...eligible for royalties on sales of PER.C6-derived products. Crucell N.V. (Euronext:CRXL; CRXL), Leiden, the Netherlands GeneMax Corp....
Items per page:
1 - 10 of 20
BioCentury | Jul 2, 2007
Company News

GeneMax, University of British Columbia deal

...not disclosed. Also, GMXX changed its name to TapImmune Inc. and its ticker to TPIM. GeneMax Corp....
BioCentury | Feb 21, 2005
Company News

GeneMax board of directors update

GeneMax Corp. (GMXX), Vancouver, B.C. Business: Cancer, Infectious Appointed: Glynn Wilson, president and CEO of Auriga Pharmaceuticals WIR Staff cancer Infectious...
BioCentury | Feb 21, 2005
Company News

GeneMax management update

GeneMax Corp. (GMXX), Vancouver, B.C. Business: Cancer, Infectious Promoted: Konstantine Sarafis to president, CEO and a director from COO; he replaces Ronald Handford, who resigned WIR Staff cancer Infectious...
BioCentury | Sep 6, 2004
Company News

GeneMax management update

GeneMax Corp. (GMXX; FSE:GX1), Vancouver, B.C. Business: Autoimmune, Cancer, Infectious Hired: Konstantine Sarafis as COO, formerly an industry consultant WIR Staff autoimmune cancer Infectious...
BioCentury | Jul 26, 2004
Clinical News

GeneMax preclinical data

...retarded tumor growth. Data were presented at the International Congress of Immunology meeting in Montreal. GeneMax Corp....
BioCentury | Jun 21, 2004
Company News

GeneMax board of directors update

GeneMax Corp. (GMXX), Blaine, Wash. Business: Cancer, Infectious, Autoimmune Resigned: Grant Atkins WIR Staff...
BioCentury | Jun 21, 2004
Company News

GeneMax management update

GeneMax Corp. (GMXX), Blaine, Wash. Business: Cancer, Infectious, Autoimmune Hired: Edward Farrauto as CFO, treasurer and secretary WIR Staff autoimmune cancer Infectious...
BioCentury | Feb 23, 2004
Company News

GeneMax, University of British Columbia deal

...GMXX's GeneMax Pharmaceuticals Inc. subsidiary (Vancouver, B.C.) received an exclusive worldwide license from the university to...
...worldwide license from the university to an assay that screens compounds that regulate immune responses. GeneMax Corp....
BioCentury | Nov 24, 2003
Company News

GeneMax, National Institutes of Health deal

GeneMax Corp. (GMXX), Blaine, Wash. National Institutes of Health , Bethesda, Md. Business: Infectious GMXX obtained a non-exclusive worldwide license from the NIH's National Institute of Allergy and Infectious Diseases (NIAID) to Modified Vaccinia Ankara IP...
BioCentury | Aug 18, 2003
Company News

Crucell, GeneMax deal

...eligible for royalties on sales of PER.C6-derived products. Crucell N.V. (Euronext:CRXL; CRXL), Leiden, the Netherlands GeneMax Corp....
Items per page:
1 - 10 of 20